Procter & Gamble Health Adjusts Evaluation Amid Strong Financial Performance and Growth

Jun 12 2025 08:05 AM IST
share
Share Via
Procter & Gamble Health has recently experienced a change in evaluation, driven by strong financial performance indicators. The company reported a 23.17% increase in net sales and a 24.76% rise in profit before tax, alongside a high return on equity and a favorable debt-to-equity ratio, highlighting its robust market position.
Procter & Gamble Health has recently undergone an adjustment in evaluation, reflecting a shift in its underlying trends and performance indicators. The company, operating within the Pharmaceuticals & Biotechnology sector, has demonstrated notable financial metrics that contribute to its revised standing.

In the latest quarter, Procter & Gamble Health reported a significant growth in net sales, reaching Rs 310.99 crore, which marks an increase of 23.17%. Additionally, the profit before tax, excluding other income, rose to Rs 75.42 crore, showcasing a growth of 24.76%. These figures highlight the company's robust operational efficiency, evidenced by a high return on equity (ROE) of 30.22%.

The stock's performance has also outpaced broader market indices, with a return of 16.72% over the past year, significantly higher than the BSE 500's return of 5.98%. Furthermore, the company maintains a low debt-to-equity ratio, indicating a strong financial position.

Overall, the adjustment in evaluation for Procter & Gamble Health reflects its solid financial foundation and market performance, underscoring its position within the industry.

Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News